HOUSTON, Nov. 1, 2023
/PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company")
(NASDAQ: NUTX), a physician-led, technology-enabled integrated
healthcare delivery system comprised of 22 state-of-the-art micro
hospitals in 8 states and primary care-centric, risk-bearing
physician networks, today announced that Thomas Vo, M.D., MBA,
Founder, Chairman and CEO will be a panelist speaker at the Danaher
Summit on Diagnostics: Insights to Impact on November 7, in Washington, D.C.
Nutex Health Speaker Details:
Date: Tuesday, November 7, 2023
Time: 1:30 PM ET
Venue: The Ritz Carlton
Address: 1150 22nd Street Northwest,
Washington, D.C. 20037
Dr. Vo will be speaking on Panel 4, "Diagnostic Insights to
Impact: The Hospital Director/Healthcare Systems." He will be
accompanied by Dr. Michael Zinner,
CEO and Executive Medical Director at Miami Cancer Institute, and
Dr. T. Clifford Deveny, President
and CEO of Summa Health.
About Nutex Health Inc.
Headquartered in Houston, Texas
and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a
healthcare management and operations company with two divisions: a
Hospital Division and a Population Health Management Division.
The Hospital Division owns, develops and operates innovative
health care models, including micro-hospitals, specialty hospitals,
and hospital outpatient departments (HOPDs). This division owns and
operates 22 facilities in 8 states.
The Population Health Management division owns and operates
provider networks such as Independent Physician Associations
(IPAs). Through our Management Services Organization (MSO), we
provide management, administrative and other support services to
our affiliated hospitals and physician groups. Our cloud-based
proprietary technology platform aggregates clinical and claims data
across multiple settings, information systems and sources to create
a holistic view of patients and providers, allowing us to deliver
greater quality care more efficiently.
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases "will", "will likely result,"
"expected to," "will continue," "anticipated," "estimate,"
"projected," "intend," "goal," or similar expressions are intended
to identify "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
are subject to certain risks, known and unknown, and uncertainties,
many of which are beyond the control of the Company. Such
uncertainties and risks include, but are not limited to, our
ability to successfully execute our growth strategy, changes in
laws or regulations, including the interim final and final rules
implemented under the No Surprises Act , economic conditions,
dependence on management, dilution to stockholders, lack of
capital, the effects of rapid growth upon the Company and the
ability of management to effectively respond to the growth and
demand for products and services of the Company, newly developing
technologies, the Company's ability to compete, conflicts of
interest in related party transactions, regulatory matters,
protection of technology, lack of industry standards, the effects
of competition and the ability of the Company to obtain future
financing. An extensive list of factors that can affect future
results are discussed in the Current Report on Form 10-Q for the
period ended March 31, 2023 under the
heading "Risk Factors" in Part I, Item IA thereof, and other
documents filed from time to time with the Securities and Exchange
Commission. Such factors could materially adversely affect the
Company's financial performance and could cause the Company's
actual results for future periods to differ materially from any
opinions or statements expressed within this press release.
View original
content:https://www.prnewswire.com/news-releases/nutex-health-chairman-and-ceo-tom-vo-to-speak-on-panel-at-upcoming-danaher-summit-on-diagnostics-301973574.html
SOURCE Nutex Health, Inc.